Multiple-Dose Fosfomycin for Complicated UTIs
In cases of complicated urinary tract infections (UTI) treated with multiple-dose fosfomycin, clinical resolution occurred in 2 of 3 treatment episodes.
Urinary Tract Infection
Novel Cephalosporin Now Available for Treatment of Complicated UTI
Fetroja® (cefiderocol) has been made available by Shionogi for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex.
UTI Recurrence in Pediatric Patients: Antibiotic Treatment Duration Examined
In pediatric patients, the duration of antibiotic treatment for uncomplicated UTI was not significantly associated with UTI recurrence.
Vegetarian Diet Linked to Lower Risk for Urinary Tract Infection
A vegetarian diet is associated with a reduced risk for urinary tract infection.
Cefiderocol Approved for Complicated UTI in Patients With Limited or No Alternative Treatment Options
The FDA has approved Fetroja for the treatment of complicated urinary tract infections.
UTI Antibiotic Use to be Improved in Nursing Homes
Enhanced implementation on adoption of evidence-based antibiotic stewardship in nursing homes focused on the recognition and management of UTIs may improve the quality of antibiotic prescription in nursing homes.
Updated Algorithm Improves Specificity of UTI Detection in Patients With Relapsing Multiple Sclerosis
With an improved specificity, an updated algorithm for the detection of UTIs in patients with relapsing MS addresses previous issues concerning the unnecessary prescription of antibiotics, whilst improving accuracy and maintaining safety.
Cefoxitin Is Efficacious in Treatment of Febrile Urinary Tract Infection in Men
A high dose and continuous infusion of cefoxitin has been associated with clinical success in treating febrile urinary tract infections in men caused by extended spectrum beta-lactamase–producing E coli.
FDA Panel Votes on Novel Antibiotic for Complicated UTI
The FDA’s Antimicrobial Drugs Advisory Committee voted in favor of approval of cefiderocol for the treatment of complicated UTIs including pyelonephritis.
Comparison of Antibiotic Activity in Complicated UTI From Gram-Negative Bacteria
Ceftazidime-avibactam was highly active against a large collection of gram-negative bacteria isolated from patients with complicated urinary tract infections.
Next post in Antibiotics, Antimicrobial Resistance
